{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:37:46Z","timestamp":1761511066107},"reference-count":87,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>Rheumatoid arthritis not only affects synovial joints but also many other sites including\nheart, blood vessels, and skins. It is more common in females than in males. The exact cause of\nrheumatoid arthritis is not well established, but the hypothesis reported in the literature is that in\nthe development stage of the disease, both genetics and environmental factors can play an inciting\nrole. Along with these factors, the alteration in the normal physiology of enzymatic action acts as a\ntrigger to develop this condition. Numerous signaling pathways in the pathogenesis of Rheumatoid\nArthritis involve activation of mitogen-activated protein kinase, kinases Janus family, P-38 Mitogen-\nActivated Protein Kinase and Nuclear Factor-kappa B. Interleukin-1, is a proinflammatory cytokine\nthat plays an important role in inflammation in RA. These are also associated with an increase\nin neutrophil, macrophage and lymphocytic chemotaxis, mast cell degranulation, activation,\nmaturation and survival of T-cells and B-cells activated. These signaling pathways also show that\np38\u03b1 downregulation in myeloid cells exacerbates the severity of symptoms of arthritis. Thus, the\npresent review carters about the detail of different signaling pathways and their role in rheumatoid\narthritis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2589977512999201109215004","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T04:21:23Z","timestamp":1605068483000},"page":"130-139","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of Signaling Pathway in the Biological Cause of Rheumatoid Arthritis"],"prefix":"10.2174","volume":"13","author":[{"given":"Rakesh Kumar","family":"Chauhan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Science, Galgotias University, Greater Noida, Uttar Pradesh 201306,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod Kumar","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Science, Galgotias University, Greater Noida, Uttar Pradesh 201306,India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Medical and Allied Science, Galgotias University, Greater Noida, Uttar Pradesh 201306,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Chen Z.","year":"2019","unstructured":"Chen Z.; Bozec A.; Ramming A.; Schett G.; Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol 2019,15(1),9-17","journal-title":"Nat Rev Rheumatol"},{"key":"ref=2","author":"Low P.S.","year":"2014","unstructured":"Low P.S.; Purdue Research Foundation, assignee. Treatment and diagnosis of macrophage mediated disease. United States patent US20020192157A1 2014","journal-title":"United States patent US20020192157A1"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1302\/2058-5241.4.180018","volume":"4","author":"Tanaka S.","year":"2019","unstructured":"Tanaka S.; Molecular understanding of pharmacological treatment of osteoporosis. EFORT Open Rev 2019,4(4),158-164","journal-title":"EFORT Open Rev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/ijms18030484","volume":"18","author":"Malemud C.J.","year":"2017","unstructured":"Malemud C.J.; Negative regulators of JAK\/STAT signaling in rheumatoid arthritis and osteoarthritis. Int J Mol Sci 2017,18(3),484","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12079-016-0326-x","volume":"10","author":"Subbannayya T.","year":"2016","unstructured":"Subbannayya T.; Variar P.; Advani J.; Nair B.; Shankar S.; Gowda H.; Saussez S.; Chatterjee A.; Prasad T.S.; An integrated signal transduction network of macrophage migration inhibitory factor. J Cell Commun Signal 2016,10(2),165-170","journal-title":"J Cell Commun Signal"},{"key":"ref=6","first-page":"13","author":"Westra J.","year":"2005","unstructured":"Westra J.; Limburg P.C.;  Signal transduction pathways in RA 2005,13-27","journal-title":"Signal transduction pathways in RA"},{"key":"ref=7","author":"Andrade M.J.","year":"2019","unstructured":"Andrade M.J.; Van Lonkhuyzen D.R.; Upton Z.; Satyamoorthy K.;  Unravelling the insulin-like growth factor I-mediated photoprotection of the skin 2019","journal-title":"Unravelling the insulin-like growth factor I-mediated photoprotection of the skin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/1735-5362.272534","volume":"14","author":"Emami J.","year":"2019","unstructured":"Emami J.; Ansarypour Z.; Receptor targeting drug delivery strategies and prospects in the treatment of rheumatoid arthritis. Res Pharm Sci 2019,14(6),471-487","journal-title":"Res Pharm Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.taap.2015.06.017","volume":"287","author":"Umar S.","year":"2015","unstructured":"Umar S.; Hedaya O.; Singh A.K.; Ahmed S.; Thymoquinone inhibits TNF-\u03b1-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Toxicol Appl Pharmacol 2015,287(3),299-305","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.fsi.2016.04.139","volume":"54","author":"Sun Y.","year":"2016","unstructured":"Sun Y.; Zhang L.; Zhang M.; Li R.; Li Y.; Hu X.; Wang S.; Bao Z.; Characterization of three mitogen-activated protein kinases (MAPK) genes reveals involvement of ERK and JNK, not p38 in defense against bacterial infection in Yesso scallop Patinopecten yessoensis. Fish Shellfish Immunol 2016,54,507-515","journal-title":"Fish Shellfish Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.intimp.2019.04.034","volume":"72","author":"Yang F.","year":"2019","unstructured":"Yang F.; Cai H.H.; Feng X.E.; Zhang Y.L.; Ge R.; Xiao B.G.; Li Q.S.; 5,2\u2032-Dibromo-2,4,5-trihydroxydiphenylmethanone, a novel immunomodulator of T lymphocytes by regulating the CD4 T cell subset balance via activating the mitogen-activated protein kinase pathway. Int Immunopharmacol 2019,72,487-495","journal-title":"Int Immunopharmacol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/ijms21010188","volume":"21","author":"Mele S.","year":"2019","unstructured":"Mele S.; Johnson T.K.; Receptor tyrosine kinases in development: insights from Drosophila.\n Int J Mol Sci 2019,21(1),188","journal-title":"Int J Mol Sci"},{"key":"ref=13","first-page":"81","volume":"30","author":"Dolfi F.","year":"2019","unstructured":"Dolfi F.; Garcia-Guzman M.; Vuori K.; p130Cas in Integrin Signaling. Signaling Through Cell Adhesion Molecules 2019,30,81","journal-title":"Signaling Through Cell Adhesion Molecules"},{"key":"ref=14","doi-asserted-by":"publisher","author":"Hu L.","unstructured":"Hu L.; Zou F.; Grandis J.R.; Johnson D.E.; The JNK Pathway in Drug Resistance. Cancer Sensitizing Agents for Chemotherapy, Targeting Cell Survival Pathways to Enhance Response to Chemotherapy. Academic Press 2019; pp. 87-100.","DOI":"10.1016\/B978-0-12-813753-6.00004-4"},{"key":"ref=15","author":"Nadal-Ribelles M.","year":"2018","unstructured":"Nadal-Ribelles M.; Sole C.; Mart\u00ednez-Cebrian G.; Posas F.; de Nadal E.; Shaping the Transcriptional Landscape through MAPK Signaling. Gene Expression and Control IntechOpen2018","journal-title":"Gene Expression and Control"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1152\/physrev.00029.2018","volume":"99","author":"Kazi J.U.","year":"2019","unstructured":"Kazi J.U.; R\u00f6nnstrand L.; FMS-like tyrosine kinase 3\/FLT3: from basic science to clinical implications. Physiol Rev 2019,99(3),1433-1466","journal-title":"Physiol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","volume":"10","author":"Malemud C.J.","year":"2018","unstructured":"Malemud C.J.; The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet 2018,10(5-6),117-127","journal-title":"Ther Adv Musculoskelet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/art.39445","volume":"68","author":"Segond von Banchet G.","year":"2016","unstructured":"Segond von Banchet G.; K\u00f6nig C.; Patzer J.; Eitner A.; Leuchtweis J.; Ebbinghaus M.; Boettger M.K.; Schaible H.G.; Long\u2010lasting activation of the transcription factor CREB in sensory neurons by interleukin\u20101\u03b2 during antigen\u2010induced arthritis in rats: a mechanism of persistent arthritis pain? Arthritis Rheum 2016,68(2),532-541","journal-title":"Arthritis Rheum"},{"key":"ref=19","first-page":"1","author":"Cronin R.J.","year":"2019","unstructured":"Cronin R.J.; The role of p90 ribosomal S6 kinases (RSKs) in Steroid signalling. Doctoral dissertation, University of Essex. 2019,1-163"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-47354-7","volume":"9","author":"Park S.W.","year":"2019","unstructured":"Park S.W.; Nhieu J.; Persaud S.D.; Miller M.C.; Xia Y.; Lin Y.W.; Lin Y.L.; Kagechika H.; Mayo K.H.; Wei L.N.; A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1. Sci Rep 2019,9(1),1-12","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/art.39588","volume":"68","author":"Arnoux F.","year":"2016","unstructured":"Arnoux F.; Fina F.; Lambert N.; Balandraud N.; Martin M.; Ouafik L.; Kanaan S.B.; Roudier J.; Auger I.; Newly Identified BRAF mutation in rheumatoid arthritis. Arthritis Rheum 2016,68(6),1377-1383","journal-title":"Arthritis Rheum"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.3390\/cancers11081133","volume":"11","author":"Dumaz N.","year":"2019","unstructured":"Dumaz N.; Jouenne F.; Delyon J.; Mourah S.; Bensussan A.; Lebb\u00e9 C.; Atypical BRAF and NRAS mutations in mucosal melanoma. Cancers (Basel) 2019,11(8),1133","journal-title":"Cancers (Basel)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cellsig.2007.12.003","volume":"20","author":"Muniyappa H.","year":"2008","unstructured":"Muniyappa H.; Das K.C.; Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism. Cell Signal 2008,20(4),675-683","journal-title":"Cell Signal"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/jcdd6030027","volume":"6","author":"Turner N.A.","year":"2019","unstructured":"Turner N.A.; Blythe N.M.; Cardiac fibroblast p38 MAPK: a critical regulator of myocardial remodeling. J Cardiovasc Dev Dis 2019,6(3),27","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","volume":"10","author":"Malemud C.J.","year":"2018","unstructured":"Malemud C.J.; The role of the JAK\/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskelet Dis 2018,10(5-6),117-127","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.20892\/j.issn.2095-3941.2019.0137","volume":"16","author":"Li Y.","year":"2019","unstructured":"Li Y.; Dong Q.; Cui Y.; Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy. Cancer Biol Med 2019,16(3),415-434","journal-title":"Cancer Biol Med"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2019-100875","author":"Dai W.L.","year":"2020","unstructured":"Dai W.L.; Bao Y.N.; Fan J.F.; Li S.S.; Zhao W.L.; Yu B.Y.; Liu J.H.; Levo-corydalmine attenuates microglia activation and neuropathic pain by suppressing ASK1-p38 MAPK\/NF-\u03baB signaling pathways in rat spinal cord. Anesth Pain Med 2020","journal-title":"Anesth Pain Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12974-019-1476-6","volume":"16","author":"Zhou D.","year":"2019","unstructured":"Zhou D.; Zhang S.; Hu L.; Gu Y.F.; Cai Y.; Wu D.; Liu W.T.; Jiang C.Y.; Kong X.; Zhang G.Q.; Inhibition of apoptosis signal-regulating kinase by paeoniflorin attenuates neuroinflammation and ameliorates neuropathic pain. J Neuroinflammation 2019,16(1),83","journal-title":"J Neuroinflammation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","volume":"80","author":"Xin P.","year":"2020","unstructured":"Xin P.; Xu X.; Deng C.; Liu S.; Wang Y.; Zhou X.; Ma H.; Wei D.; Sun S.; The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 2020,80,106210","journal-title":"Int Immunopharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"i43","DOI":"10.1093\/rheumatology\/key276","volume":"58","author":"Fragoulis G.E.","year":"2019","unstructured":"Fragoulis G.E.; McInnes I.B.; Siebert S.; JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis. Rheumatology (Oxford) 2019,58(Suppl. 1),i43-i54","journal-title":"Rheumatology (Oxford)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","volume":"35","author":"Waldmann T.A.","year":"2017","unstructured":"Waldmann T.A.; Chen J.; Disorders of the JAK\/STAT pathway in T cell lymphoma pathogenesis: implications for immunotherapy. Annu Rev Immunol 2017,35,533-550","journal-title":"Annu Rev Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/rheumatology\/keu430","volume":"54","author":"Isom\u00e4ki P.","year":"2015","unstructured":"Isom\u00e4ki P.; Junttila I.; Vidqvist K.L.; Korpela M.; Silvennoinen O.; The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels. Rheumatology (Oxford) 2015,54(6),1103-1113","journal-title":"Rheumatology (Oxford)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nrd.2017.201","volume":"16","author":"Schwartz D.M.","year":"2017","unstructured":"Schwartz D.M.; Kanno Y.; Villarino A.; Ward M.; Gadina M.; O\u2019Shea J.J.; JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov 2017,16(12),843-862","journal-title":"Nat Rev Drug Discov"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-immunol-042718-041447","volume":"37","author":"Lin J.X.","year":"2019","unstructured":"Lin J.X.; Leonard W.J.; Fine-tuning cytokine signals. Annu Rev Immunol 2019,37(37),295-324","journal-title":"Annu Rev Immunol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"9846312","DOI":"10.1155\/2019\/9846312","volume":"2019","author":"Moshapa F.T.","year":"2019","unstructured":"Moshapa F.T.; Riches-Suman K.; Palmer T.M.; Therapeutic targeting of the proinflammatory IL-6-JAK\/STAT signalling pathways responsible for vascular restenosis in type 2 diabetes mellitus. Cardiol Res Pract 2019,2019,9846312","journal-title":"Cardiol Res Pract"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fphys.2019.00117","volume":"10","author":"Rex J.","year":"2019","unstructured":"Rex J.; Lutz A.; Faletti L.E.; Albrecht U.; Thomas M.; Bode J.G.; Borner C.; Sawodny O.; Merfort I.; IL-1\u03b2 and TNF\u03b1 differentially influence NF-\u03baB activity and FasL-induced apoptosis in primary murine hepatocytes during LPS-induced inflammation. Front Physiol 2019,10(10),117","journal-title":"Front Physiol"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1177\/0963689720938023","volume":"29","author":"Wang J.","year":"2020","unstructured":"Wang J.; Zhao Q.; Linc02381 exacerbates rheumatoid arthritis through adsorbing miR-590-5p and activating the mitogen-activated protein kinase signaling pathway in rheumatoid arthritis-fibroblast-like synoviocytes. Cell Transplant 9636897209380232020,29","journal-title":"Cell Transplant"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1159\/000484889","volume":"44","author":"Li F.","year":"2017","unstructured":"Li F.; Xiao H.; Zhou F.; Hu Z.; Yang B.; Study of HSPB6: insights into the properties of the multifunctional protective agent. Cell Physiol Biochem 2017,44(1),314-332","journal-title":"Cell Physiol Biochem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"352371","DOI":"10.1155\/2014\/352371","volume":"2014","author":"Yang Y.","year":"2014","unstructured":"Yang Y.; Kim S.C.; Yu T.; Yi Y.S.; Rhee M.H.; Sung G.H.; Yoo B.C.; Cho J.Y.; Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm 2014,2014,352371","journal-title":"Mediators Inflamm"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"Cuenda A.","year":"2007","unstructured":"Cuenda A.; Rousseau S.; p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007,1773(8),1358-1375","journal-title":"Biochim Biophys Acta"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1111\/febs.13250","volume":"282","author":"Gupta J.","year":"2015","unstructured":"Gupta J.; Nebreda A.R.; Roles of p38\u03b1 mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. FEBS J 2015,282(10),1841-1857","journal-title":"FEBS J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.12659\/MSM.916317","volume":"25","author":"Cao Y.X.","year":"2019","unstructured":"Cao Y.X.; Huang D.; Liu J.; Zong R.K.; Wan L.; Huang C.B.; Zhang W.D.; Wang Y.; A novel Chinese medicine, Xinfeng capsule, modulates proinflammatory cytokines via regulating the Toll-Like Receptor 4 (TLR4)\/Mitogen-Activated Protein Kinase (MAPK)\/Nuclear Kappa B (NF-\u03baB) signaling pathway in an adjuvant arthritis rat model. Med Sci Monit 2019,25,6767-6774","journal-title":"Med Sci Monit"},{"key":"ref=43","author":"Topping L.","year":"2019","unstructured":"Topping L.; Targeting microvesicles to the arthritic joint using antibodies specific to damaged cartilage (doctoral dissertation) 2019"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.chembiol.2018.10.011","volume":"26","author":"Shraga A.","year":"2019","unstructured":"Shraga A.; Olshvang E.; Davidzohn N.; Khoshkenar P.; Germain N.; Shurrush K.; Carvalho S.; Avram L.; Albeck S.; Unger T.; Lefker B.; Subramanyam C.; Hudkins R.L.; Mitchell A.; Shulman Z.; Kinoshita T.; London N.; Covalent docking identifies a potent and selective MKK7 inhibitor. Cell Chem Biol 2019,26(1),98-108.e5","journal-title":"Cell Chem Biol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"Johnson G.L.","year":"2002","unstructured":"Johnson G.L.; Lapadat R.; Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002,298(5600),1911-1912","journal-title":"Science"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cells7110217","volume":"7","author":"Hsia C.H.","year":"2018","unstructured":"Hsia C.H.; Velusamy M.; Jayakumar T.; Chen Y.J.; Hsia C.W.; Tsai J.H.; Teng R.D.; Sheu J.R.; Mechanisms of TQ-6, a novel ruthenium-derivative compound, against lipopolysaccharide-induced in vitro macrophage activation and liver injury in experimental mice: the crucial role of p38 MAPK and NF-\u03baB signaling. Cells 2018,7(11),217","journal-title":"Cells"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","volume":"13","author":"Baker R.G.","year":"2011","unstructured":"Baker R.G.; Hayden M.S.; Ghosh S.; NF-\u03baB, inflammation, and metabolic disease. Cell Metab 2011,13(1),11-22","journal-title":"Cell Metab"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-04816-7_2","author":"Chapman M.A.","year":"2019","unstructured":"Chapman M.A.; Sundberg C.J.; Exercise, gene regulation, and cardiometabolic disease. Cardiorespiratory Fitness in Cardiometabolic Diseases 2019,11-22","journal-title":"Cardiorespiratory Fitness in Cardiometabolic Diseases"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/art.40865","volume":"71","author":"Ter Haar N.M.","year":"2019","unstructured":"Ter Haar N.M.; van Dijkhuizen E.H.P.; Swart J.F.; van Royen-Kerkhof A.; El Idrissi A.; Leek A.P.; de Jager W.; de Groot M.C.H.; Haitjema S.; Holzinger D.; Foell D.; van Loosdregt J.; Wulffraat N.M.; de Roock S.; Vastert S.J.; Treatment to target using recombinant Interleukin-1 receptor antagonist as First-Line monotherapy in New-Onset systemic juvenile idiopathic arthritis: results from a Five-Year Follow-Up study. Arthritis Rheumatol 2019,71(7),1163-1173","journal-title":"Arthritis Rheumatol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/nrrheum.2016.166","volume":"12","author":"Schett G.","year":"2016","unstructured":"Schett G.; Dayer J.M.; Manger B.; Interleukin-1 function and role in rheumatic disease. Nat Rev Rheumatol 2016,12(1),14-24","journal-title":"Nat Rev Rheumatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s00432-019-02909-z","volume":"145","author":"Gamboa-Cede\u00f1o A.M.","year":"2019","unstructured":"Gamboa-Cede\u00f1o A.M.; Castillo M.; Xiao W.; Waldmann T.A.; Ranuncolo S.M.; Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively. J Cancer Res Clin Oncol 2019,145(6),1437-1448","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"Tesmer L.A.","year":"2008","unstructured":"Tesmer L.A.; Lundy S.K.; Sarkar S.; Fox D.A.; Th17 cells in human disease. Immunol Rev 2008,223(1),87-113","journal-title":"Immunol Rev"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"Liu T.","year":"2017","unstructured":"Liu T.; Zhang L.; Joo D.; Sun S.C.; NF-\u03baB signaling in inflammation. Sig Transduct Target Ther 2017,2,17023","journal-title":"Sig Transduct Target Ther"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/bs.apcsb.2019.09.004","volume":"119","author":"Khandia R.","year":"2020","unstructured":"Khandia R.; Munjal A.; Interplay between inflammation and cancer. Adv Protein Chem Struct Biol 2020,119,199-245","journal-title":"Adv Protein Chem Struct Biol"},{"key":"ref=55","first-page":"155","author":"Hu J.","year":"2019","unstructured":"Hu J.; Pezzella F.; The signalling pathways in cancer. Oxford Textbook of Cancer Biology 2019,155-177","journal-title":"Oxford Textbook of Cancer Biology"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-816992-6.00001-2","author":"Brahmachari G.","year":"2019","unstructured":"Brahmachari G.; Discovery and development of anti-inflammatory agents from natural products: an overview. Natural Product Drug Discovery 2019","journal-title":"Natural Product Drug Discovery"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"i103","DOI":"10.1136\/ard.59.suppl_1.i103","volume":"59","author":"Schiff M.H.","year":"2000","unstructured":"Schiff M.H.; Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis. Ann Rheum Dis 2000,59(59)(Suppl. 1),i103-i108","journal-title":"Ann Rheum Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"102369","DOI":"10.1016\/j.autrev.2019.102369","volume":"18","author":"Di Benedetto P.","year":"2019","unstructured":"Di Benedetto P.; Ruscitti P.; Vadasz Z.; Toubi E.; Giacomelli R.; Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun Rev 2019,18(10),102369","journal-title":"Autoimmun Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/icb.2012.4","volume":"90","author":"Sakaguchi S.","year":"2012","unstructured":"Sakaguchi S.; Benham H.; Cope A.P.; Thomas R.; T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. Immunol Cell Biol 2012,90(3),277-287","journal-title":"Immunol Cell Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1242\/jcs.042762","volume":"122","author":"Huse M.","year":"2009","unstructured":"Huse M.; The T-cell-receptor signaling network. J Cell Sci 2009,122(Pt 9),1269-1273","journal-title":"J Cell Sci"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","volume":"6","author":"Mellado M.","year":"2015","unstructured":"Mellado M.; Mart\u00ednez-Mu\u00f1oz L.; Cascio G.; Lucas P.; Pablos J.L.; Rodr\u00edguez-Frade J.M.; T cell migration in rheumatoid arthritis. Front Immunol 2015,6(6),384","journal-title":"Front Immunol"},{"key":"ref=62","first-page":"73","volume":"22","author":"Arellano B.","year":"2016","unstructured":"Arellano B.; Graber D.J.; Sentman C.L.; Regulatory T cell-based therapies for autoimmunity. Discov Med 2016,22(119),73-80","journal-title":"Discov Med"},{"key":"ref=63","first-page":"160","volume":"4","author":"Malemud C.J.","year":"2013","unstructured":"Malemud C.J.; Intracellular signaling pathways in rheumatoid arthritis. J Clin Exp Immunol 2013,4,160","journal-title":"J Clin Exp Immunol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.3390\/ijms20153792","volume":"20","author":"Lu N.","year":"2019","unstructured":"Lu N.; Malemud C.J.; Extracellular signal-regulated kinase: a regulator of cell growth, inflammation, chondrocyte and bone cell receptor-mediated gene expression. Int J Mol Sci 2019,20(15),3792","journal-title":"Int J Mol Sci"},{"key":"ref=65","author":"Dong S.","unstructured":"Dong S.; Pharmacologic and genetic investigation of PI3K p110delta in chronic lymphocytic Leukemia. Doctoral dissertation, The Ohio State University."},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","volume":"67","author":"Weichhart T.","year":"2008","unstructured":"Weichhart T.; S\u00e4emann M.D.; The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis 2008,67(67)(Suppl. 3),iii70-iii74","journal-title":"Ann Rheum Dis"},{"key":"ref=67","first-page":"693","volume":"20","author":"Ren F.","year":"2012","unstructured":"Ren F.; Zhang H.Y.; Piao Z.F.; Zheng S.J.; Chen Y.; Chen D.X.; Duan Z.P.; Inhibition of glycogen synthase kinase 3b activity regulates Toll-like receptor 4-mediated liver inflammation. 2012,20(9),693-697"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/jcmm.14129","volume":"23","author":"Zhu L.","year":"2019","unstructured":"Zhu L.; Li C.; Liu Q.; Xu W.; Zhou X.; Molecular biomarkers in cardiac hypertrophy. J Cell Mol Med 2019,23(3),1671-1677","journal-title":"J Cell Mol Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1021\/acs.biochem.9b00932","volume":"58","author":"Aoto P.C.","year":"2019","unstructured":"Aoto P.C.; Stanfield R.L.; Wilson I.A.; Dyson H.J.; Wright P.E.; A dynamic switch in inactive p38\u03b3 leads to an excited state on the pathway to an active kinase. Biochemistry 2019,58(51),5160-5172","journal-title":"Biochemistry"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"Banerjee S.","year":"2017","unstructured":"Banerjee S.; Biehl A.; Gadina M.; Hasni S.; Schwartz D.M.; JAK\u2013STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 2017,77(5),521-546","journal-title":"Drugs"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.2174\/0929867325666180514112124","volume":"26","author":"Ferrer M.D.","year":"2019","unstructured":"Ferrer M.D.; Busquets-Cort\u00e9s C.; Cap\u00f3 X.; Tejada S.; Tur J.A.; Pons A.; Sureda A.; Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr Med Chem 2019,26(18),3225-3241","journal-title":"Curr Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.14412\/1995-4484-2016-60-77","volume":"54","author":"Nasonov E.L.","year":"2016","unstructured":"Nasonov E.L.; Eliseev M.S.; Role of interleukin 1 in the development of human diseases. Rheumatology Science and Practice 2016,54(1),60-77","journal-title":"Rheumatology Science and Practice"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.aller.2015.10.005","volume":"44","author":"Maddah M.","year":"2016","unstructured":"Maddah M.; Harsini S.; Rezaei A.; Sadr M.; Zoghi S.; Moradinejad M.H.; Ziaee V.; Rezaei N.; Association of Interleukin-2, but not Interferon-Gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr) 2016,44(4),303-306","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines8010009","volume":"8","author":"Deviatkin A.A.","year":"2020","unstructured":"Deviatkin A.A.; Vakulenko Y.A.; Akhmadishina L.V.; Tarasov V.V.; Beloukhova M.I.; Zamyatnin A.A.; Lukashev A.N.; Emerging concepts and challenges in rheumatoid arthritis gene therapy. Biomedicines 2020,8(1),1-23","journal-title":"Biomedicines"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/1440-1681.12946","volume":"45","author":"Dong C.","year":"2018","unstructured":"Dong C.; Fu T.; Ji J.; Li Z.; Gu Z.; The role of interleukin-4 in rheumatic diseases. Clin Exp Pharmacol Physiol 2018,45(8),747-754","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/14397595.2018.1546357","volume":"29","author":"Ogata A.","year":"2019","unstructured":"Ogata A.; Kato Y.; Higa S.; Yoshizaki K.; IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol 2019,29(2),258-267","journal-title":"Mod Rheumatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.4049\/jimmunol.1201675","volume":"190","author":"Chen Z.","year":"2013","unstructured":"Chen Z.; Kim S.J.; Chamberlain N.D.; Pickens S.R.; Volin M.V.; Volkov S.; Arami S.; Christman J.W.; Prabhakar B.S.; Swedler W.; Mehta A.; Sweiss N.; Shahrara S.; The novel role of IL-7 ligation to IL-7 receptor in myeloid cells of rheumatoid arthritis and collagen-induced arthritis. J Immunol 2013,190(10),5256-5266","journal-title":"J Immunol"},{"key":"ref=78","first-page":"19","volume":"12","author":"Slavic V.","year":"2005","unstructured":"Slavic V.; Stankovic A.; Kamenov B.; The role of interleukin-8 and monocyte chemotactic protein-1 in rheumatoid arthritis. Facta Universitatis 2005,12(1),19-22","journal-title":"Facta Universitatis"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/eji.201040879","volume":"41","author":"Stephens G.L.","year":"2011","unstructured":"Stephens G.L.; Swerdlow B.; Benjamin E.; Coyle A.J.; Humbles A.; Kolbeck R.; Fung M.; IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease. Eur J Immunol 2011,41(4),952-962","journal-title":"Eur J Immunol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrrheum.2012.170","volume":"9","author":"Pope R.M.","year":"2013","unstructured":"Pope R.M.; Shahrara S.; Possible roles of IL-12-family cytokines in rheumatoid arthritis. Nat Rev Rheumatol 2013,9(4),252-256","journal-title":"Nat Rev Rheumatol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fimmu.2016.00339","volume":"7","author":"Aouinti S.","year":"2016","unstructured":"Aouinti S.; Giudicelli V.; Duroux P.; Malouche D.; Kossida S.; Lefranc M.P.; IMGT\/StatClonotype for pairwise evaluation and visualization of NGS IG and TR IMGT clonotype (AA) diversity or expression from IMGT\/HighV-QUEST. Front Immunol 2016,7(7),339","journal-title":"Front Immunol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.addr.2006.01.008","volume":"58","author":"Abramson S.B.","year":"2006","unstructured":"Abramson S.B.; Yazici Y.; Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv Drug Deliv Rev 2006,58(2),212-225","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/rheumatology\/ken061","volume":"47","author":"Sakurai N.","year":"2008","unstructured":"Sakurai N.; Kuroiwa T.; Ikeuchi H.; Hiramatsu N.; Maeshima A.; Kaneko Y.; Hiromura K.; Nojima Y.; Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatology (Oxford) 2008,47(6),815-820","journal-title":"Rheumatology (Oxford)"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13075-017-1309-x","volume":"19","author":"Nakachi S.","year":"2017","unstructured":"Nakachi S.; Sumitomo S.; Tsuchida Y.; Tsuchiya H.; Kono M.; Kato R.; Sakurai K.; Hanata N.; Nagafuchi Y.; Tateishi S.; Kanda H.; Okamura T.; Yamamoto K.; Fujio K.; Interleukin-10-producing LAG3 regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther 2017,19(1),97","journal-title":"Arthritis Res Ther"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","volume":"39","author":"Noack M.","year":"2017","unstructured":"Noack M.; Miossec P.;  Seminars in immunopathology 2017,39(4),365-383","journal-title":"Seminars in immunopathology"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.drudis.2015.08.002","volume":"22","author":"Hsu Y.H.","year":"2017","unstructured":"Hsu Y.H.; Chang M.S.; IL-20 in rheumatoid arthritis. Drug Discov Today 2017,22(6),960-964","journal-title":"Drug Discov Today"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2567.2010.03281.x","volume":"131","author":"Woodward E.A.","year":"2010","unstructured":"Woodward E.A.; Pr\u00eale C.M.; Nicholson S.E.; Kolesnik T.B.; Hart P.H.; The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1). Immunology 2010,131(1),118-127","journal-title":"Immunology"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977512999201109215004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/187757\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/2589977512999201109215004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T20:28:05Z","timestamp":1659990485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/187757\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977512999201109215004","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}